Accent Capital Management LLC Has $4.07 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Accent Capital Management LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,966 shares of the healthcare conglomerate’s stock after selling 478 shares during the period. UnitedHealth Group accounts for approximately 2.4% of Accent Capital Management LLC’s investment portfolio, making the stock its 9th largest holding. Accent Capital Management LLC’s holdings in UnitedHealth Group were worth $4,073,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. China Universal Asset Management Co. Ltd. grew its stake in shares of UnitedHealth Group by 20.6% in the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after purchasing an additional 1,857 shares in the last quarter. Quent Capital LLC raised its position in shares of UnitedHealth Group by 5.5% during the 1st quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after buying an additional 217 shares in the last quarter. Connors Investor Services Inc. acquired a new position in shares of UnitedHealth Group during the first quarter valued at approximately $201,000. Edgestream Partners L.P. lifted its position in UnitedHealth Group by 314.3% in the first quarter. Edgestream Partners L.P. now owns 6,073 shares of the healthcare conglomerate’s stock worth $3,004,000 after purchasing an additional 4,607 shares during the period. Finally, Hillsdale Investment Management Inc. increased its position in shares of UnitedHealth Group by 8.0% during the 1st quarter. Hillsdale Investment Management Inc. now owns 2,923 shares of the healthcare conglomerate’s stock valued at $1,446,000 after purchasing an additional 216 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Cantor Fitzgerald increased their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Finally, KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

NYSE UNH opened at $592.23 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $545.02 billion, a P/E ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The stock’s 50-day moving average is $582.84 and its two-hundred day moving average is $549.52. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $6.56 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.